Page last updated: 2024-12-07

cyclolaudenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Cyclolaudenol is a triterpene alcohol found in various plants. It has been isolated from the bark of *Alstonia scholaris*, a plant used in traditional medicine for its anti-inflammatory and antimicrobial properties. The molecule exhibits a unique structure with a cyclopropane ring, which is thought to contribute to its biological activity. Research on cyclolaudenol is focused on understanding its potential therapeutic applications, particularly as an anti-inflammatory agent. Cyclolaudenol has shown promising results in laboratory studies, reducing inflammation and inhibiting the production of inflammatory mediators. Its potential as a treatment for inflammatory conditions like arthritis and skin inflammation is being investigated. Studies have explored its synthesis, with methods like Grignard reactions and Diels-Alder cycloadditions being employed to construct its complex structure. Further research is needed to elucidate its mechanism of action and evaluate its safety and efficacy in clinical trials.'

cyclolaudenol : A pentacyclic triterpenoid that is (24S)-methyl-9beta,19-cyclolanost-25-ene which carries a hydroxy group at position 3beta. It is isolated from several plant species inclduing Turraeanthus and Tillandsia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Turraeanthusgenus[no description available]MeliaceaeThe mahogany plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID101729
CHEMBL ID376381
CHEBI ID142990
SCHEMBL ID679913
MeSH IDM0081887

Synonyms (19)

Synonym
cyclolaudenol
511-61-5
CHEMBL376381
CHEBI:142990
(24s)-24-methylcycloart-25-en-3beta-ol
24(s)-methyl-9beta,19-cyclolanost-25-en-3beta-ol
(3beta,9beta,24s)-24-methyl-9,19-cyclolanost-25-en-3-ol
37a519ww2t ,
(3beta,24s)-24-methyl-9,19-cyclolanost-25-en-3-ol
unii-37a519ww2t
9,19-cyclo-9.beta.-lanost-25-en-3.beta.-ol, 24-methyl-, (24s)-
9,19-cyclolanost-25-en-3-ol, 24-methyl-, (3.beta.,24s)-
9,19-cyclo-9.beta.-lanost-25-en-3.beta.-ol, 24-methyl-
SCHEMBL679913
(24s)-24-methylcycloarta-25-en-3-beta-ol
C22175
Q27256667
(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,5s)-5,6-dimethylhept-6-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol
DTXSID501317556
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
3beta-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the beta-position.
pentacyclic triterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID288760Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 320 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288764Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288761Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288762Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 3.2 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288766Scavenging activity against NO generation in human Chang liver cells assessed as inhibition of NOR1-activation at 350 nM relative to NOR12007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288765Cell viability of Raji cells at 320 nM2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288763Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 0.32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]